NEW YORK (GenomeWeb) – GATC Biotech will offer its clients full access to Qiagen's Ingenuity Variant Analysis solution under a non-exclusive deal announced today by Qiagen. 

Under the terms of the deal, GATC clients will also have access to interpretation services. Ingenuity Variant Analysis is a bioinformatics platform that enables laboratories to evaluate data generated by high-throughput next-generation sequencing technologies. It filters genetic variants in a cloud-based environment to identify those most likely to cause disease. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.